Adroit Pharma Research Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.90 M
- Revenue Growth -5.98%
- Profit Growth -30.18%
- Ebitda 8.94%
- Net Worth 29.04%
- Total Assets 32.26%
About Adroit Pharma Research
Adroit Pharma Research Private Limited (APRPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 November 1999 and has a history of 25 years and two months. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Sharda Drychem Private Limited. The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company has closed loans amounting to ₹2.90 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Nipakumari Makadia, Shilpakumari Makadia, Rajulkumar Makadia, and Three other members serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ1999PTC036905
-
Company No.
036905
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Nov 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Adroit Pharma Research Private Limited offer?
Adroit Pharma Research Private Limited offers a wide range of products and services, including Amine Compounds, Benzylamine, Chemical Reagents & Catalysts, Organic Acid, API (Active Pharmaceutical Ingredients), Industrial Chemicals & Supplies, Liquid Phenol.
Who are the key members and board of directors at Adroit Pharma Research?
Board Members (6)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rajulkumar Makadia
![]() |
Director | 03-Feb-2016 | Current |
Jeetkumar Makadia
![]() |
Director | 20-Dec-2021 | Current |
Nipakumari Makadia
![]() |
Whole-Time Director | 30-Jan-2004 | Current |
Shilpakumari Makadia
![]() |
Whole-Time Director | 01-Aug-2024 | Current |
Sonal Sinojia
![]() |
Whole-Time Director | 20-Dec-2021 | Current |
Priti Sinojia
![]() |
Whole-Time Director | 20-Dec-2021 | Current |
Financial Performance of Adroit Pharma Research.
Adroit Pharma Research Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 5.98% decrease. The company also saw a substantial fall in profitability, with a 30.18% decrease in profit. The company's net worth Soared by an impressive increase of 29.04%.
![Graph illustrating revenue growth over time](/Images/financial/revenue-growth.webp)
![Graph showing profit and loss trends over time](/Images/financial/profit-loss.webp)
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Adroit Pharma Research?
In 2021, Adroit Pharma Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
![Shareholding Indicator graph](/Images/tcc-login/Shareholding-Indiacator-1200.webp)
Charges (Loans)
₹0
₹2.90 M
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 0.29 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Mar 2000 | Bank Of Baroda | ₹2.90 M | Satisfied |
How Many Employees Work at Adroit Pharma Research?
Unlock and access historical data on people associated with Adroit Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
![Graph showing employee growth trends](/Images/tcc-login/Employee-Graph.webp)
Deals i
![Graph showing company valuation over time](/Images/tcc-login/Valuation-Graph-small.webp)
Gain comprehensive insights into the Deals and Valuation data of Adroit Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adroit Pharma Research's trajectory.
Rating
![Graph displaying rating trends over time](/Images/tcc-login/Rating-Graph-small.webp)
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
![Alert Indicator](/Images/tcc-login/Alert-Indicator-small.webp)
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.